Gilead Sciences
GILD
#98
Rank
NZ$314.70 B
Marketcap
NZ$253.65
Share price
-1.06%
Change (1 day)
36.24%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$17.01 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.08 Billion. In 2024 the company made an earning of NZ$1.15 Billion a decrease over its 2023 earnings that were of NZ$11.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$17.01 B1369.5%
2024 NZ$1.15 B-89.94%
2023 NZ$11.51 B17.97%
2022 NZ$9.75 B-29.77%
2021 NZ$13.89 B395.99%
2020 NZ$2.80 B-67.66%
2019 NZ$8.66 B-33.84%
2018 NZ$13.09 B-42.35%
2017 NZ$22.70 B-20.87%
2016 NZ$28.69 B-21.06%
2015 NZ$36.35 B45.8%
2014 NZ$24.93 B253.01%
2013 NZ$7.06 B16.51%
2012 NZ$6.06 B-1.07%
2011 NZ$6.12 B-6.71%
2010 NZ$6.56 B11.75%
2009 NZ$5.87 B29.5%
2008 NZ$4.53 B19.11%
2007 NZ$3.81 B-455.74%
2006 -NZ$1.08 Billion-154.93%
2005 NZ$1.95 B76.99%
2004 NZ$1.10 B-266.16%
2003 -NZ$0.67 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$93.68 M-242.15%
2000 -NZ$65.91 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$83.59 Million8.73%
1997 -NZ$76.88 Million27.22%
1996 -NZ$60.43 Million
1994 -NZ$57.58 Million26.57%
1993 -NZ$45.49 Million46.49%
1992 -NZ$31.06 Million362.5%
1991 -NZ$6.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.37 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.89 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.78 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.77 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.83 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.19 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.67 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.48 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.75 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA